Abstract
Drug addiction and alcoholism are behavioural disorders characterized by a profound alteration of several brain circuits induced by chronic drug use. Their treatment is yet based on empiricism and today only few pharmacological strategies are fully effective to control both drug use and relapse. The present paper reviews the most updated pharmacotherapies able to contrast both alcoholism and drug addiction including the new patented drugs and the future therapeutic trends.
Keywords: Alcoholism, addiction, buprenorphine, methadone, suboxone®, naltrexone, gamma-hydroxybutyrrate, nociceptin peptide receptors, CB1 cannabinoid receptors, dopamine
Recent Patents on CNS Drug Discovery (Discontinued)
Title: New Frontiers in Alcoholism and Addiction Treatment
Volume: 5 Issue: 1
Author(s): Felice Nava, Andrea Vendramin, Ezio Manzato, Mauro Cibin and Alfio Lucchini
Affiliation:
Keywords: Alcoholism, addiction, buprenorphine, methadone, suboxone®, naltrexone, gamma-hydroxybutyrrate, nociceptin peptide receptors, CB1 cannabinoid receptors, dopamine
Abstract: Drug addiction and alcoholism are behavioural disorders characterized by a profound alteration of several brain circuits induced by chronic drug use. Their treatment is yet based on empiricism and today only few pharmacological strategies are fully effective to control both drug use and relapse. The present paper reviews the most updated pharmacotherapies able to contrast both alcoholism and drug addiction including the new patented drugs and the future therapeutic trends.
Export Options
About this article
Cite this article as:
Nava Felice, Vendramin Andrea, Manzato Ezio, Cibin Mauro and Lucchini Alfio, New Frontiers in Alcoholism and Addiction Treatment, Recent Patents on CNS Drug Discovery (Discontinued) 2010; 5 (1) . https://dx.doi.org/10.2174/157488910789753567
DOI https://dx.doi.org/10.2174/157488910789753567 |
Print ISSN 1574-8898 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3954 |
Related Articles
-
Overview of the Recent Advances in Pathophysiology and Treatment for Autism
CNS & Neurological Disorders - Drug Targets Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?
CNS & Neurological Disorders - Drug Targets Infectious Burden: A New Risk Factor and Treatment Target for Atherosclerosis
Infectious Disorders - Drug Targets The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
Reviews on Recent Clinical Trials GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Is “Leptin Resistance” Another Key Resistance to Manage Type 2 Diabetes?
Current Diabetes Reviews The Role of Transcranial Magnetic Stimulation in Treatment-Resistant Depression: A Review
Current Pharmaceutical Design Stress, Depression, Resilience and Ageing: A Role for the LPA-LPA1 Pathway
Current Neuropharmacology Post-Translational Modifications of PTEN and their Potential Therapeutic Implications
Current Cancer Drug Targets Treatment of Insulin Resistance in the Neurodegeneration
Recent Patents on CNS Drug Discovery (Discontinued) Neuropeptides as Possible Targets in Sleep Disorders: Special Emphasis on Hypocretin-Deficient Narcolepsy
CNS & Neurological Disorders - Drug Targets Borna Disease Virus (BDV): Neuropharmacological Effects of a CNS Viral Infection
Current Neuropharmacology Cingulate Volume Abnormalities in Emerging Psychosis
Current Pharmaceutical Design Impact of Early Life Stress on the Pathogenesis of Mental Disorders: Relation to Brain Oxidative Stress
Current Pharmaceutical Design Molecular Pharmacology of the Glycine Receptor Chloride Channel
Current Pharmaceutical Design The Cell Cycle and Hormonal Fluxes in Alzheimer Disease: A Novel Therapeutic Target
Current Pharmaceutical Design Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine
CNS & Neurological Disorders - Drug Targets Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies
CNS & Neurological Disorders - Drug Targets Pituitary Volume in Patients with Primary Empty Sella and Clinical Relevance to Pituitary Hormone Secretion: A Retrospective Single Center Study
Current Medical Imaging Keeping Obesity and Metabolic Syndrome at Bay with Central Leptin and Cytokine Gene Therapy
Current Medicinal Chemistry - Central Nervous System Agents